Your browser doesn't support javascript.
Plasma ACE2 activity is persistently elevated following SARS-CoV-2 infection: implications for COVID-19 pathogenesis and consequences.
Patel, Sheila K; Juno, Jennifer A; Lee, Wen Shi; Wragg, Kathleen M; Hogarth, P Mark; Kent, Stephen J; Burrell, Louise M.
  • Patel SK; Dept of Medicine, Austin Health, University of Melbourne, Melbourne, Australia.
  • Juno JA; Contributed equally.
  • Lee WS; Dept of Microbiology and Immunology, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
  • Wragg KM; Contributed equally.
  • Hogarth PM; Dept of Microbiology and Immunology, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
  • Kent SJ; Dept of Microbiology and Immunology, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
  • Burrell LM; Immune Therapies Group, Burnet Institute, Melbourne, Australia.
Eur Respir J ; 57(5)2021 05.
Article in English | MEDLINE | ID: covidwho-1043608
Preprint
This scientific journal article is probably based on a previously available preprint. It has been identified through a machine matching algorithm, human confirmation is still pending.
See preprint
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Peptidyl-Dipeptidase A / COVID-19 Limits: Humans Language: English Year: 2021 Document Type: Article Affiliation country: 13993003.03730-2020

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Peptidyl-Dipeptidase A / COVID-19 Limits: Humans Language: English Year: 2021 Document Type: Article Affiliation country: 13993003.03730-2020